FDA Inspection 1285934 — Novel Laboratories, Inc. d.b.a Lupin Somerset

Novel Laboratories, Inc. d.b.a Lupin Somerset — FEI 3006271438

The FDA completed an inspection of Novel Laboratories, Inc. d.b.a Lupin Somerset on October 10, 2025 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 10, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Somerset, NJ (United States)

Citations

IDCFRDescription
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures